FindTrial
Sign In

NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

DRUG3 trials

Sponsors

NanOlogy, LLC

Conditions

Genital Neoplasms, MaleLocalized CancerLocally Advanced Pancreatic CarcinomaLung CancerLung Cancer, Nonsmall CellLung Cancer, Small CellNeoplasm of LungProstate Adenocarcinoma

Phase 2

Trial of NanoPac Focal Therapy for Prostate Cancer
TerminatedNCT04221828
NanOlogy, LLCGenital Neoplasms, Male, Localized Cancer, Prostate Adenocarcinoma +4
Start: 2020-10-20End: 2021-02-08Updated: 2022-03-29
Trial of NanoPac Intratumoral Injection in Lung Cancer
CompletedNCT04314895
NanOlogy, LLCLung Cancer, Lung Cancer, Nonsmall Cell, Lung Cancer, Small Cell +1
Start: 2021-04-14End: 2023-09-26Updated: 2025-05-23

Unknown Phase

Expanded Access to NanoPac
NCT03756311
NanOlogy, LLCLocally Advanced Pancreatic Carcinoma, Lung Cancer, Prostate Cancer
Updated: 2026-01-23

Related Papers

Safety of locally administered large surface area microparticle paclitaxel and docetaxel in combination with standard of care cancer therapies.
Journal of Clinical Oncology2023-06-011 citations